 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Kezar Life Sciences, Inc. Nasdaq: KZR, a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Noreen Roth Henig, M.D., Chief Medical Officer, will participate in a panel called Developing Therapies Against Novel Targets in Autoimmune Diseases at the William Blair Biotech Focus Conference in New York, NY. The panel will be held in person on Wednes 